Pharmaceuticals

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Trend Stats

1-Month Return +5.60%
3-Month Return +9.38%
12-Month Return +31.03%
Volatility Score 1.7
RSI 52.7
ST Trend Neutral
LT Trend Up

Short-Term Trend

Neutral

The Short-Term Trend is a metric that gauges an ETF's short-term price trend.

Long-Term Trend

Up

The Long-Term Trend is a metric that gauges an ETF's long-term price trend.

Performance

Pharmaceuticals
S&P 500 Index

Components

Symbol Company Market Cap 12 mo return Performance over the past 12 months 3 mo return Performance over the past 3 months 1 mo return Performance over the past month Vol Score Our gauge of the ETF's recent volatility ST Trend A metric that gauges an ETF's short-term price trend LT Trend A metric that gauges an ETF's long-term price trend
LLY Eli Lilly & Co $1T +59.05% +2.29% +3.17% 3.1 Down Up
JNJ Johnson&Johnson $663B +57.73% +21.22% +8.50% 1.9 Up Up
ABBV AbbVie $453B +24.40% +14.82% +5.19% 2.1 Neutral Up
MRK Merck $371B +83.40% +25.90% +17.45% 2.8 Up Up
NVS Novartis Sp ADR $304B +27.05% +7.81% +4.38% 2.0 Neutral Up
AZN ASTRAZENECA $252B +1.28% -9.91% +5.25% 1.9 Down Down
NVO Nordisk Sp ADR-B $206B -11.56% +7.88% +6.58% 2.6 Down Up
PFE Pfizer $162B +22.37% +12.68% +11.96% 2.2 Up Up
BMY Bristol-MyersSqu $136B +48.55% +19.39% +1.41% 2.1 Up Up
SNY SANOFI SP ADR $106B +0.41% -0.32% +3.66% 1.5 Neutral Down
MCK Mckesson $106B +32.61% +20.08% +9.46% 2.4 Up Up
GSK GSK Sp ADR $100B +27.56% -1.81% -2.31% 2.1 Down Down
COR Cencora $63B +14.01% +22.67% +8.26% 2.4 Up Up
TAK TAKEDA PHARM SP ADR $59B +24.61% +19.42% +11.41% 1.5 Up Up
TEVA TEVAPHARMIND SP ADR $42B +91.87% +5.61% +5.61% 2.7 Up Up
HLN Haleon Sp ADR $42B -0.06% +7.85% -1.19% 1.7 Down Down
ZTS Zoetis-A $31B -49.60% -4.00% -0.30% 3.5 Neutral Down
VTRS Viatris $19B +66.46% +6.96% -3.92% 2.5 Neutral Up
JAZZ Jazz Pharmaceuti $16B +90.59% +2.81% -5.66% 3.0 Down Up
ELAN ELANC ANIML HLTH $12B +32.94% -0.85% -4.30% 3.6 Down Up
CORT Corcept Therapeu $12B +60.93% +49.05% +1.66% 3.7 Up Up
AXSM Axsome Therapeut $11B +65.12% -10.71% -2.59% 3.3 Down Up
OGN Organon $3.6B +33.84% +2.99% +1.77% 0.3 Neutral Up
BHC BAUSCH HEALTH $2.5B -10.75% +24.71% +1.86% 4.7 Up Up
PRGO Perrigo $2.1B -27.92% +42.71% +41.26% 3.8 Up Up